IL99008A0 - Immunosuppressant peptides and pharmaceutical compositions containing them - Google Patents

Immunosuppressant peptides and pharmaceutical compositions containing them

Info

Publication number
IL99008A0
IL99008A0 IL99008A IL9900891A IL99008A0 IL 99008 A0 IL99008 A0 IL 99008A0 IL 99008 A IL99008 A IL 99008A IL 9900891 A IL9900891 A IL 9900891A IL 99008 A0 IL99008 A0 IL 99008A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
immunosuppressant
peptides
immunosuppressant peptides
Prior art date
Application number
IL99008A
Other languages
English (en)
Original Assignee
Cytel Corp
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytel Corp, Sandoz Ag filed Critical Cytel Corp
Publication of IL99008A0 publication Critical patent/IL99008A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL99008A 1990-08-01 1991-07-30 Immunosuppressant peptides and pharmaceutical compositions containing them IL99008A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56061590A 1990-08-01 1990-08-01
US65448291A 1991-02-12 1991-02-12

Publications (1)

Publication Number Publication Date
IL99008A0 true IL99008A0 (en) 1992-07-15

Family

ID=27072401

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99008A IL99008A0 (en) 1990-08-01 1991-07-30 Immunosuppressant peptides and pharmaceutical compositions containing them

Country Status (6)

Country Link
AU (1) AU8305491A (fr)
IE (1) IE912701A1 (fr)
IL (1) IL99008A0 (fr)
MX (1) MX9100454A (fr)
PT (1) PT98501A (fr)
WO (1) WO1992002543A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005011A1 (fr) * 1991-08-29 1993-03-18 Sandoz Ltd. Nouveaux immunosuppresseurs
US7252829B1 (en) 1998-06-17 2007-08-07 Idm Pharma, Inc. HLA binding peptides and their uses
US7611713B2 (en) 1993-03-05 2009-11-03 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide compositions
US9340577B2 (en) 1992-08-07 2016-05-17 Epimmune Inc. HLA binding motifs and peptides and their uses
ATE280180T1 (de) * 1992-08-31 2004-11-15 Ludwig Inst Cancer Res Vom mage-3-gen abgeleitetes und von hla-a1 präsentiertes, isoliertes nonapeptid und dessen anwendungen
US6222012B1 (en) 1992-08-31 2001-04-24 Ludwig Institute For Cancer Research Isolated nonapeptides presented by HLA molecules, and uses thereof
US5405940A (en) * 1992-08-31 1995-04-11 Ludwig Institute For Cancer Research Isolated nonapeptides derived from MAGE genes and uses thereof
US5589458A (en) * 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same
US5385918A (en) * 1993-02-09 1995-01-31 Miles Inc. Aminomethylene-peptides as immunosuppressants
US6413935B1 (en) 1993-09-14 2002-07-02 Epimmune Inc. Induction of immune response against desired determinants
JP3926839B2 (ja) 1993-09-14 2007-06-06 エピミューン，インコーポレイティド 万能ｄｒ−結合性ペプチドを用いる免疫応答の改変
US6509165B1 (en) 1994-07-08 2003-01-21 Trustees Of Dartmouth College Detection methods for type I diabetes
WO1996040753A1 (fr) * 1995-06-07 1996-12-19 G.D. Searle & Co. Derives d'acide pipecolique obtenus a partir d'amides de threoline et de proline utiles dans le traitement de l'arthrite rhumatoide
AU1749597A (en) * 1996-01-19 1997-08-11 Virginia Mason Research Center Allele-specific peptide epitope strategy for vaccine development
GB9702377D0 (en) * 1996-02-23 1997-03-26 Zeneca Ltd Peptide derivatives
CA2252417A1 (fr) 1996-06-07 1997-12-11 Zeneca Limited Derives de peptides
GB9621836D0 (en) * 1996-10-19 1996-12-11 Zeneca Ltd Peptide compounds
GB9624562D0 (en) 1996-11-27 1997-01-15 Zeneca Ltd Peptide derivatives
US6413517B1 (en) 1997-01-23 2002-07-02 Epimmune, Inc. Identification of broadly reactive DR restricted epitopes
FR2763071B1 (fr) * 1997-05-07 2003-05-16 Centre Nat Rech Scient Analogues peptidiques, et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic
WO2000005249A2 (fr) * 1998-07-23 2000-02-03 The President And Fellows Of Harvard College Peptides synthetiques et procedes d'utilisation de ceux-ci dans des therapies de maladies auto-immunes
ES2527760T3 (es) 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
CA2337688C (fr) 1998-07-23 2016-04-05 Yeda Research And Development Co., Ltd. Traitement de maladies auto-immunes a l'aide du copolymere 1 et copolymeres associes
US6800287B2 (en) 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
EP1128839A4 (fr) * 1998-11-12 2002-10-09 Yeda Res & Dev Compositions pharmaceutiques comprenant des copolymeres de peptides synthetiques et methodes de prevention et de traitement de la reaction du greffon contre l'hote (gvhd) et de la reaction de l'hote contre le greffon (hvgd)
US7053043B1 (en) 1999-07-23 2006-05-30 Yeda Research And Development Co.Ltd. Pharmaceutical compositions comprising synthetic peptide copolymers and methods for preventing and treating GVHD and HVGD
DK1230268T3 (da) 1999-11-18 2010-02-08 Epimmune Inc Heteroklitiske analoger af klasse I-epitoper
US7026443B1 (en) 1999-12-10 2006-04-11 Epimmune Inc. Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
US7462354B2 (en) 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
ZA200206457B (en) 2000-02-18 2003-08-13 Yeda Res & Dev Oral, nasal and pulmonary dosage formulations of copolymer 1.
US20020077278A1 (en) 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
WO2002076503A1 (fr) 2000-06-20 2002-10-03 Mayo Foundation For Medical Education And Research Traitement de maladies du systeme nerveux central au moyen d'anticorps diriges contre l'acetate de glatiramere
WO2003029276A2 (fr) * 2001-10-03 2003-04-10 President And Fellows Of Harvard College Copolymeres destines a la suppression de maladies auto-immunes, et methodes d'utilisation
WO2003048735A2 (fr) 2001-12-04 2003-06-12 Teva Pharmaceutical Industries, Ltd. Procedes pour mesurer la puissance de l'acetate de glatiramer
US7655221B2 (en) 2004-05-07 2010-02-02 Peptimmune, Inc. Methods of treating disease with random copolymers
CN111704651B (zh) * 2020-07-27 2021-10-08 南京安吉生物科技有限公司 具有抗衰老作用的多肽rv3和rv4及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3514587A1 (de) * 1985-04-23 1986-10-30 Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl Pharmakologisch aktive peptide
WO1990008161A1 (fr) * 1989-01-12 1990-07-26 The Blood Center Of Southeastern Wisconsin Modulation par peptides mediateurs de la reconnaissance d'antigenes par les lymphocytes t, utilises comme moyens d'affectation de reactions immunitaires

Also Published As

Publication number Publication date
PT98501A (pt) 1992-05-29
MX9100454A (es) 1992-04-01
IE912701A1 (en) 1992-02-12
WO1992002543A1 (fr) 1992-02-20
AU8305491A (en) 1992-03-02

Similar Documents

Publication Publication Date Title
IL99008A0 (en) Immunosuppressant peptides and pharmaceutical compositions containing them
GB2270842B (en) Pharmaceutical compositions containing cyclosporins
IL103910A0 (en) New peptide derivatives and pharmaceutical compositions containing them
IL103612A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
GB2222770B (en) Pharmaceutical compositions containing cyclosporins
IL105218A0 (en) Hexanones and pharmaceutical compositions containing them
IL105223A0 (en) Cyclohexane-ylidenes and pharmaceutical compositions containing them
IL116512A0 (en) Cyclic peptides their preparation and pharmaceutical compositions containing them
EP0539319A3 (en) Pharmaceutical cyclosporin composition
IL100364A0 (en) Benzodiazepinones,their preparation and pharmaceutical compositions containing them
IL106098A0 (en) Heteroarylnaphthalenes and pharmaceutical compositions containing them
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
IL110929A0 (en) Multiple branch peptide constructions and pharmaceutical compositions containing them
IL108031A0 (en) Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
IL99009A0 (en) Polypeptides,their preparation and pharmaceutical compositions containing them
ZA911065B (en) Chemical and pharmaceutical compositions
NZ245239A (en) Hemoregulatory peptides and pharmaceutical compositions
ZA944769B (en) Thf-gamma2 analogs and pharmaceutical compositions comprising them
GB2269821B (en) Memory enhancing peptides and pharmaceutical compositions containing them
IL106352A0 (en) Pyridoindolo-benzodiazepines and pharmaceutical compositions containing them
IL119412A0 (en) Gonadotropins and pharmaceutical compositions containing them
IL104296A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
IL102688A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
LTIP1528A (en) Novel peptides and pharmaceutical compositions containing them